Will Actinogen Ace Alzheimer's?
Alzheimerās disease is an incurable neurodegenerative disorder that robs the affected individuals of memory, self-care and quality of life,...
424 Views
AK Medical: Take It If The Answers Are Good
AK Medical Holdings (1789 HK) is a new listing with a proposed price range of HKD1.66 -2.00. The company is China's leading (in volume) orthopedic...
773 Views
Biosimilar Battlefield: Celltrion Forecasts
This Insight uses the biosimilar market model discussed inĀ Surveying The Biosimilar BattlefieldĀ to build a long-term revenue forecast for the...
637 Views
Astellas (4503) - PROSPER Data Revives Value Story
For a drug that was targeted to hit US$6~8bil in sales, last yearās US$2.3bil revenue figure for Xtandi was decidedly below par. With the start of...
314 Views
Update on Astellas (4503) As It Gets Orphan Drug Status for Gilteritinib
News that gilteritinib has received orphan drug status for acute myeloid leukaemia (AML) would be rather more exciting for Astellas (4503 JP) but...
347 Views